🔗 Permalink

Inventor profile of:

Henry J. Smith

City:

Temecula, California

Country:

United States

Published Applications:

Last publication date:

2025-07-24

Top Assignees for applications by Henry J. Smith

The entities that hold a legal rights for patent applications filed by inventor Smith Henry J.:

Epinex Diagnostics, Inc. 2 Tustin, CA United States

Recent patent applications by Smith Henry J.

Henry J. Smith from Temecula, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-07-24

US20250235594A1

Human necessities

TARGETED APHERESIS TO TREAT INFLAMMATION

#2 | 2022-09-08

US20220280631A1

Human necessities

VIRAL PANDEMIC VACCINE

#3 | 2022-07-28

US20220233755A1

Human necessities

Targeted apheresis to treat preeclampsia

#4 | 2022-01-13

US20220008636A1

Human necessities

APHERESIS TO REMOVE INTERFERING SUBSTANCES

#5 | 2022-01-13

US20220008511A1

Human necessities

TUMOR TREATMENT USING CYTOKINES AND CANCER DRUGS

#6 | 2021-01-14

US20210008215A1

Human necessities

OPTIMIZING DRUG DELIVERY

#7 | 2020-08-20

US20200262903A1

Chemistry; metallurgy

Treatment of age-related macular degeneration

#8 | 2020-04-16

US20200113828A1

Human necessities

Thermally Stabilized Nanoemulsion

#9 | 2020-03-05

US20200069861A1

Human necessities

APHERESIS TO REDUCE HIGH BLOOD PRESSURE IN PRE-ECLAMPSIA

#10 | 2019-01-24

US20190022005A1

Human necessities

Multi-Drug Lipsomes to Treat Tumors

#11 | 2016-04-21

US20160106905A1

Human necessities

Targeted apheresis for the treatment of rheumatoid arthritis and immune disorders

#12 | 2015-11-19

US20150328305A1

Human necessities

Viral immunogenic compositions

#13 | 2015-07-02

US20150182632A1

Human necessities

ANTI-INTERLEUKIN-1 (IL-1) ANTIBODY USED AS A TARGETING AGENT TO TREAT ARTHRITIS AND OTHER DISEASES

#14 | 2014-07-03

US20140186435A1

Human necessities

SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR (STNF-R) USED AS A TARGETING AGENT TO TREAT ARTHRITIS AND OTHER DISEASES

#15 | 2014-07-03

US20140186434A1

Human necessities

ANTI-TUMOR NECROSIS FACTOR ALPHA (TNF-A) ANTIBODY USED AS A TARGETING AGENT TO TREAT ARTHRITIS AND OTHER DISEASES

#16 | 2014-06-19

US20140170766A1

Physics

Aptamer Based Point-of-Care Test for Glycated Albumin

#17 | 2013-12-12

US20130330402A1

Human necessities

ANTINUCLEAR ANTIBODY UTILIZED AS A TARGETING AGENT FOR PHARMACEUTICAL COMPOUNDS USED IN THE TREATMENT OF CANCER AND OTHER DISEASES

#18 | 2013-02-14

US20130039973A1

Human necessities

Viral Immunogenic Compositions

#19 | 2012-06-28

US20120165781A1

Human necessities

TARGETED APHERESIS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS

#20 | 2010-11-25

US20100298753A1

Human necessities

TARGETED APHERESIS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS

#21 | 2010-09-30

US20100247650A1

Chemistry; metallurgy

TREATMENT FOR PRE-ECLAMPSIA IN PREGNANT WOMEN USING TARGETED APHERESIS

#22 | 2010-06-17

US20100151488A1

Physics

Rapid Test for Glycated Albumin

#23 | 2010-04-22

US20100098698A1

Human necessities

TARGETED APHERESIS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS

#24 | 2006-07-20

US20060159680A1

Human necessities

Targeted apherisis for the treatment of rheumatoid arthritis

#25 | 2006-07-13

US20060153835A1

Chemistry; metallurgy

Treatment of pre-eclampsia in pregnant women using targeted apheresis

#26 | 2006-05-25

US20060111295A1

Human necessities

Cellular receptors utilized as carrier agents for pharmaceutical compounds used in the treatment of arthritis, inflammation and immune disorders

InventorID:

89376 ⎘